Adherence to Treatment Guidelines in Ambulatory Heart Failure Patients with Reduced Ejection Fraction in a Latin-American Country: Observational Study of the Colombian Heart Failure Registry (RECOLFACA).
Alex Rivera-ToquicaLuis Eduardo EcheverríaCarlos Andrés Arias-BarreraFernán Mendoza-BeltránDiego Hernán Hoyos-BallesterosCarlos Andrés Plata-MosqueraJuan Carlos Ortega-MadariagaJuan Fernando Carvajal-EstupiñánViviana Quintero-YepesLuz Clemencia Zárate-CorreaÁngel Alberto García-PeñaNelly Velásquez-LópezClaudia Victoria AnchiqueClara Ines SaldarriagaJuan Esteban Gómez-MesaPublished in: Cardiology (2024)
Prescription rates and target dose achievement are suboptimal in Colombia. Nevertheless, RECOLFACA had one of the highest prescription rates of beta-blockers and MRAs compared to some of the most recent HF registries. However, ARNIs remain underprescribed. Continuous registry updates can improve the identification of patients suitable for ARNI and SGLT2i therapy to promote their use in clinical practice.